The prognostic significance of postoperative residual contrast enhancement on CT scan in pediatric patients with medulloblastoma
- 1 November 1992
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 14 (3), 263-270
- https://doi.org/10.1007/bf00172602
Abstract
The clinical and therapeutic features of 20 patients with medulloblastoma treated at Childrens' Hospital and Medical Center, Seattle, from 1980 to 1987, were retrospectively analyzed with regard to prognosis. The overall actuarial 5-year survival rate was 63%, with 57% of patients free from recurrence at 5 years. Residual contrast enhancement on CT scans taken immediately postoperatively was associated with a significantly decreased 5-year recurrence-free survival rate; the 5-year recurrence-free survival rate was 100% for those patients without post-operative residual enhancement compared to 41% for those patients with residual enhancement. A high risk group of patients with residual contrast enhancement persisting one year following diagnosis was identified. No patient in this group survived without disease progression. Other factors, including sex, age at diagnosis, evidence of tumor dissemination, or extent of surgical resection as reported by the neurosurgeon, did not significantly influence prognosis.Keywords
This publication has 29 references indexed in Scilit:
- The treatment of medulloblastomaJournal of Neurosurgery, 1990
- Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I)European Journal of Cancer and Clinical Oncology, 1990
- Medulloblastoma at the joint center for radiation therapy between 1968 and 1984.The influence of radiation dose on the patterns of failure and survivalCancer, 1988
- Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.Journal of Clinical Oncology, 1987
- A review of the factors influencing the prognosis of medulloblastomaJournal of Neurosurgery, 1987
- Postoperative contrast enhancement in patients with brain tumorAnnals of Neurology, 1985
- Medulloblastoma: The identification of prognostic subgroups and implications for multimodality managementCancer, 1983
- Radiation treatment for medulloblastomaJournal of Neurosurgery, 1981
- Period of risk for recurrence in medulloblastomaJournal of Neurosurgery, 1978
- Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survivalCancer, 1971